USD 125.30
Price
3.77
(3.10%)
Day Change
|
|
---|
NBIX, the overall quality is very good (Quality = 85) but the timing to buy is ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
Quality Factors |
|
55% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 8 |
Magic Formula Rank by ROA |
1422
|
Magic Formula Rank by ROE |
1422
|
Magic Formula Rank by ROIC |
1174
|
Price | 125.30 |
PBV / Sector |
4.52 / 1.31
|
Earning Per Share | 3.78 |
PE / Sector |
32.15 / 32.60
|
PEG or PE/Growth / Sector |
0.29 / -51.45
GREAT
|
Average 1M Daily Value |
114.65 M
GREAT
|
Average 1W Daily Value |
142.92 M
GREAT
|
Timing Factors |
|
71% |
Financial Health |
|
52% |
Ability to Make Profit |
|
75% |
Return to Investors |
|
4% |
Registration Details |
Analyze Date | 2024-11-06 20:04:53 |
Symbol | NBIX |
Name | NEUROCRINE BIOSCIENCES INC |
Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
Market | NASDAQ |
Listed Shares | 101.25 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 12,304.55 / 12,306.98 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |